These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 8072193)

  • 1. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
    Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
    Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
    Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
    Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
    Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
    Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
    Ishikawa S; Yura J; Shinagawa N; Mizuno A; Mashita K; Hori K
    Jpn J Antibiot; 1994 Jun; 47(6):820-5. PubMed ID: 8072192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
    Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. I. The combined effect of arbekacin with fosfomycin or clavulanic acid/ticarcillin].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Aug; 45(8):949-57. PubMed ID: 1433901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum].
    Nasuhara K; Takatsuka K; Takatsuka N; Teraoka M; Tokita S; Shinohara M; Azuma E; Saijo N; Sone H; Saito I
    Jpn J Antibiot; 1994 Jun; 47(6):720-30. PubMed ID: 8072180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic efficacies of combined uses of arbekacin and various antibiotics against methicillin-resistant Staphylococcus aureus].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1994 Jun; 47(6):693-700. PubMed ID: 8072177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro studies on the combined effects of arbekacin and fosfomycin on methicillin-resistant Staphylococcus aureus].
    Watanabe T; Kanno M; Sobu K; Takase Y; Yoshida T
    Jpn J Antibiot; 1995 Feb; 48(2):284-92. PubMed ID: 7745817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. II. Synergistic actions of cefotiam with arbekacin and minocycline].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
    Jpn J Antibiot; 1993 Feb; 46(2):123-9. PubMed ID: 8331772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Kono K; Takeda S; Tatara I; Arakawa K
    Jpn J Antibiot; 1994 Jun; 47(6):710-9. PubMed ID: 8072179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with arbekacin and fosfomycin for methicillin-resistant Staphylococcus aureus infections.
    Kono K; Takeda S; Tatara I; Arakawa K; Tanaka H; Miyake S; Minamikawa H; Hoshino H; Sato M; Hattori F
    Jpn J Antibiot; 1994 Jun; 47(6):798-803. PubMed ID: 8072189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Oct; 45(10):1305-11. PubMed ID: 1479682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus isolated from patients of a pediatrics ward].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1993 Sep; 46(9):794-800. PubMed ID: 8254899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus].
    Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1997 Jan; 50(1):1-11. PubMed ID: 9059909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
    Ishii T; Takayama Y; Takase Y; Orikasa Y
    Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Staggered intensive chemotherapy using arbekacin, fosfomycin and ceftazidime on polymicrobial infections involving MRSA].
    Tanaka T; Iida-Tanaka K; Takahara J; Fujioka Y; Tamura T; Yamanoi Y; Houjou S; Takahashi T; Miki S; Nakamura Y
    Jpn J Antibiot; 1994 Jun; 47(6):790-7. PubMed ID: 8072188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological study of Arbekacin-resistant, methicillin resistant Staphylococcus aureus in Saitama Medical School Hospital].
    Yamazaki T; Endo K; Tominaga K; Fukuda M; Maesaki S; Hashikita G; Itabashi A
    Kansenshogaku Zasshi; 2004 Apr; 78(4):305-11. PubMed ID: 15176234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effect of arbekacin on MRSA infections after gastrointestinal surgery].
    Ochiai M; Tanimura H; Noguchi K; Takifuji K; Konishi R; Ohkouchi N; Kouno N; Ohnishi H; Shimada K; Kasitani M
    Jpn J Antibiot; 1994 Jun; 47(6):837-43. PubMed ID: 8072194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin.
    Nakazawa H; Kikuchi Y; Honda T; Isago T; Nozaki M
    J Infect Chemother; 2003 Dec; 9(4):304-9. PubMed ID: 14691650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.